PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+1.86%)
As of: Oct 22, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Operating Margin (2010 - 2012)

Updated

PharmaCyte Biotech's Operating Margin was -13851.65% in FY2013 (year ended Apr 30, 2013), down 10923.11 percentage points from -2928.55% in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Operating Margin (2010 - 2012) Analysis & Trends

  • Per Business Quant data, Operating Margin in earlier fiscal years was -2928.55% in FY2012 (-2620.32 pp) and -308.23% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 PharmaCyte Biotech 3.79 Mn -69.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -5,547.89%
Jul 31, 2012 -8,131.39%
Apr 30, 2012 -7,227.51%
Jan 31, 2012 -2,022.51%
Oct 31, 2011 -2,034.52%
Jul 31, 2011 -3,302.30%
Apr 30, 2011 -432.24%
Jan 31, 2011 -214.77%
Oct 31, 2010 -120.85%
Jul 31, 2010 -294.27%
API Access

PharmaCyte Biotech Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=PMCB&period=max&api_key=YOUR_API_KEY